|
Published by: Global Industry Analysts
Published: Oct. 1, 2009 - 63 Pages
Table of Contents
- 1.INDUSTRY OVERVIEW
- Genetic Engineering: A Prelude
- The Evolution and Progress of GM Crops
- GM Crops Gain Global Acceptance
- GM Cultivation Gains Prominence in Developing Nations
- Rising Prices, Food Shortage Make Biotech Grains Attractive
- Challenges to GM Crops Adoption
- Biotech Regulatory Measures Hinder Crop Domestication
- Governments Not to Give Up on GM Hope
- US - The Largest Producer of GM Crops
- Major Market Participants
- 2.MARKET DYNAMICS
- Global Food Demand to Drive Need for GM Crops
- Genetic Engineering - A Solution for Food Crisis!
- Harmful or Healthy: Breaking The Myth About GM Crops
- Non-food Sectors to Benefit from GE Technology
- Genetic Engineering and Enzymes
- GE to Help Starch and Sugar Processing Enzyme Market
- GE to Drive Demand for Bakery Enzymes
- 3.ISSUES AND CONCERNS
- The GM Food Issue Continues
- Nations at Crossroads to Accept or Object GE Crops
- Nations Set Global Agenda to Settle GM Crop Controversies
- 4.REGIONAL TRENDS
- US Soybean and Corn Crop to Witness Robust Growth
- GMO Crops’ Future Hinges on Co-Existence Measures in EU
- UK Government’s GM Crops Proposal Faces Rebuff
- Spanish Transgenic Corn Plantation Increases
- Chinese Biopharmaceutical Market to Continue its Growth Spurt
- Government to Support Biopharmaceutical Innovation
- India - The Leading Cultivator of Bt Cotton
- India Ousts China in Bt Cotton Cultivation
- GM Crops to Earn Good Returns for Australia
- Biotechnology - A Boon for Agriculture in Malaysia
- Biotech Crops Cultivation Zooms in South Africa
- 5.GENETIC ENGINEERING: AN OVERVIEW
- The Concept
- Molecular Basics - The Gene
- Genome - The Information Pool
- Evolution of Genetic Engineering
- Historical Developments in Genetic
- Engineering:
- The Human Genome Project
- Significant Events in the Past
- Gene Therapy
- Types of Gene Therapy
- Monogenic Gene Therapy
- Suicide Gene Therapy
- Antisense Gene Therapy
- Human Genetic Engineering
- Genetic Engineering in Animals
- Role of Biotechnology in Agriculture
- Insect Resistant Crops Vs. Herbicide Tolerant Crops
- Genetically Modified Foods
- GM Food Faces Worldwide Criticism During Initial Years
- Benefits of Genetically Modified Foods
- Pest Resistance
- Cold Tolerance
- Herbicide Tolerance
- Drought and Salinity Tolerance
- Disease Resistance
- Phytoremediation
- Nutrition
- Pharmaceuticals
- Negative Impacts of GM Foods
- Possibility of Crosspollination
- Decreased Pesticides Effectiveness
- Unintentional Destruction of Other Species
- Health Concerns Related to GM Foods
- Cost Concerns Related to GM Foods
- Genetic Engineering and Food Processing
- Genetic Engineering and Regulatory Environment
- Patents - An Overview
- 6.GENE THERAPY - A REVIEW
- Factors Influencing Gene Therapy’s Future Development
- Human Genome Analysis
- Gene Therapy - The Next Generation Cardiovascular Therapy
- Public Support for Gene Therapy
- RNAi Bode Bright Prospects
- Factors Hampering Gene Therapy Future
- Development
- Stringent US and European Regulatory Laws Prolongs Gene Therapy Development
- Identifying Genetic Fault
- Immune Response
- Delivering Genetic Materials into Patient Cells
- Multigene Disorders
- Side Effects
- Push Towards Germline Gene Transfer
- Technical Limitations
- Commercialization: A Road Uphill
- Time Line in Gene Therapy Drug Development
- Table 1: Gene Therapy Clinical Trials (2007): Percentage Breakdown by Geographic Region for the US, Europe, Canada, Japan and Rest of World
- Table 2: Gene Therapy Clinical Trials Worldwide (2007): A Split by Development Phase
- Various Gene Therapy Products Under Development (2007)
- Target Diseases and Players Involved
- Key Players by Application Area
- Table 3: Gene Therapy Clinical Trials Worldwide (2007): Percentage Breakdown by Disease/ Application Area for Cancer, Heart Disease, Monogenic Diseases,Infectious Diseases and Others
- Table 4: Gene Therapy Clinical Trials Worldwide (2007):Percentage Breakdown by Gene Type Transferred for Antigen, Cytokine, Tumor Suppressor, Growth Factor, Suicide, Deficiency and Others
- Table 5: Gene Therapy Clinical Trials Worldwide (2007): Percentage breakdown by Vector Type for Adenovirus, Retrovirus, Naked/Plasmid DNA, Lipofection, Vaccinia Virus, Poxvirus, Adeno- associated Virus, and Others
- Gene Therapy Industry in Europe and the US -A Comparison
- 7.RESEARCH AND DEVELOPMENT
- Anti-Clotting Drug from GE Goats to Win Approval
- British Midlands University to Reveal Genetic Code of Bacterium Causing Hospital Acquired Infection
- Genetically Engineered BMPs to Facilitate Bone Formation in Orthopedic Surgeries
- GE Finds Application in Obesity Control
- Trubion Develops Advanced mAbs
- New Study Reveals microRNA’s Role in Heart Failure
- Cell-based Assays to Aid in Early Drug Discovery
- Inhibition of SHIP Gene to Minimize Risk in Stem Cell Transplants
- Drug Discovery to Employ Chemical Genetics
- GE to Aid in the Discovery of New Enzyme Sources
- Demand for Lactose-Free Products Boosts Enzymes Applications Market
- 8.MERGERS & ACQUISITIONS
- RJH Industries Acquires Philippines Royal Oil
- Monsanto Takes Over Aly Participacoes
- Monsanto Acquires De Ruiter Seeds Group
- Lydall Announces Acquisition of DSM Solutech
- Biotie Completes Acquisition of elbion
- Pfizer Animal Health Acquires Catapult Genetics
- Monsanto Completes Marmot Acquisition
- BioEnergy Takes Over Assets of OmniGene Bioproducts
- BRAIN Takes Over Industrial Biotech Assets of MerLion Pharmaceuticals
- MTS Health Investors Acquires DNA Diagnostic Center
- Bayer HealthCare Takes Over Direvo Biotech
- QIAGEN Completes Acquisition of Corbett Life Science
- ChemVentures to Acquire BioFocus DPI Chemistry Facility
- Nanobac Pharmaceuticals to Take Over DNAPrint Genomics
- GlaxoSmithKline to Take Over Genelabs Technologies
- Invitrogen Merges with Applied Biosystems
- NitroMed Enters into Definitive Merger Agreement with Archemix
- Monsanto Completes Acquisition of Delta & Pine Land
- Inverness Medical Innovations Acquires Biosite
- Avesta Biotherapeutics Takes Over Siegfried Biologics
- Entelos Takes Over Iconix Biosciences
- Illumina Takes Over Solexa
- Celera Group Acquires Atria Genetics
- CytoDyn Acquires Advanced Genetic Technologies
- Takeda Europe to Take Over Paradigm Therapeutics
- AmerisourceBergen Announces Acquisition of IgG of America
- GlaxoSmithKline Plans Praecis Acquisition
- 9.RECENT INDUSTRY ACTIVITY
- Eureka, Glycos Partner to Develop Bacterium for Biorefinery
- Genzyme Acquires Rights to MabCampath, Fludara and Leukine
- Quantel Announces Genetic Engineering Technology Support for Lasergraphics
- USDA to Deregulate Syngenta’s GE Corn
- Archer Daniels, Deere & Company and Monsanto to Form Partnership
- Genzyme Collaborates with ICGEB
- Veredus Partners with STMicroelectronics to Establish Bio-Application Lab
- Invitrogen Gains License for Stem Cell Line
- Millipore Enters into Agreement with Solabia
- Advanced Cell Forms Joint Venture with CHA Biotech
- Luminex Enters into Agreement with Mingyuan
- ProGenTech Inks Agreement with Human Genetic Signatures
- Monsanto and China National Seed Group Sign Agreement
- Monsanto and Syngenta Sign Royalty-Bearing Licensing Agreement
- Affymetrix Signs Definitive Agreement with Panomics
- Sanofi-Aventis to Use Regeneron’s Genetic Modification Method
- Monsanto to Build DEKALB Corn Seed Production Facility
- Qatar Receives Grant to Augment Agro-Genetic Engineering Capacity
- Monsanto Expands Jerseyville Facility
- Sirtris Pharmaceuticals Obtains Approval for NamPRT
- Origin Agritech Obtains License for Phytase Corn
- Shenyang Xiehe Establishes Genetic Engineering Subsidiary
- BioServe Enters into Alliance with DNAPrint Genomics
- Evogene Teams Up with Ormat on Biodiesel
- EMD and Dendritic Nanotechnologies Enter into License and Supply Agreement
- AureoGen Biosciences Enters into Agreement with Takara Bio
- Shanghai Wanxing Inks Agreement with Blue Blood Biotech
- Stem Cell Sciences Signs Agreement with RIKEN Centre
- Olympus and National Center for Biological Sciences Open New Facility
- Biocentury Obtains Approval for Hybrid Cotton Seed in India
- Novozymes to Expand Operation Base
- Cell Therapeutics to Develop More Targeted Treatments for Cancer
- 10.PRODUCT/SERVICE LAUNCHES
- Affymetrix Introduces MyGeneChip Program
- Genomnz to Unveil DNA Testing Service
- Whatman Introduces EasiCollect
- Nanoxis Launches Membrane Protein
- Few Important Terms Used in Genetic
- Engineering
- Chromosomes
- Genome
- Recombinant DNA
- Retroviruses
- Plasmids
- Transgenic Animals and Plants
- Gene Therapy
- GLOBAL DIRECTORY
AbstractThe global outlook series on Genetic Engineering provides a collection of market briefs and concise summaries of research findings. The report offers a bird’s eye view of the industry, highlights latest developments, and discusses demand drivers, issues and concerns, and regulatory environment. Discussion on the industry’s most noteworthy regional market, the US, is amply detailed with unbiased research commentary to provide the reader a rudimentary understanding of the prevailing market climate. The report also provides select data on regional markets. Also included is an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of 169 companies active in the market.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Titles available via "online download" are not affected by this and are still delivered to your reading room immediately.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports,
company profiles and country profiles from over 700 research firms. Our reports will
provide you with the critical business and competitive intelligence you need for strategic planning and marketing
research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2012
|